We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$146M
AUM Growth
-$8M
Cap. Flow
+$7.94M
Cap. Flow %
5.44%
Top 10 Hldgs %
77.88%
Holding
70
New
1
Increased
28
Reduced
8
Closed
7

Top Buys

Rank Stock Value
1
CRDF icon
Cardiff Oncology
CRDF
+$1.94M
2
KALA icon
KALA BIO
KALA
+$1.73M
3
SCYX icon
SCYNEXIS
SCYX
+$637K
4
ELEV
Elevation Oncology
ELEV
+$489K
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$377K

Top Sells

Rank Stock Value
1
ENJY
Enjoy Technology, Inc. Common Stock
ENJY
+$1.04M
2
BCIC
BCP Investment Corp
BCIC
+$633K
3
CZOO
Cazoo Group Ltd
CZOO
+$579K
4
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$480K
5
SCOAU
ScION Tech Growth I Unit
SCOAU
+$364K

Sector Composition

Rank Sector Weight
1 Healthcare 77.56%
2 Financials 5.46%
3 Communication Services 3.37%
4 Technology 2.29%
5 Consumer Discretionary 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
$24M 16.45%
8,083,442
– –
MTEM
2
DELISTED
Molecular Templates, Inc.
MTEM
$16.7M 11.46%
142,533
+1,000
+0.7% +$131K
CRDF icon
3
Cardiff Oncology
CRDF
$59.8M
$15.6M 10.68%
2,343,333
+228,493
+11% +$1.94M
SCYX icon
4
SCYNEXIS
SCYX
$44.5M
$11M 7.51%
186,078
+10,092
+6% +$637K
SVRA icon
5
Savara
SVRA
$1.13B
$10.1M 6.93%
5,951,015
+198,800
+3% +$358K
KALA icon
6
KALA BIO
KALA
$15.7M
$9.04M 6.19%
683
+110
+19% +$1.73M
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$8.64M 5.92%
443,959
– –
GLD icon
8
SPDR Gold Trust
GLD
$130B
$6.76M 4.63%
40,820
– –
RZLT icon
9
Rezolute
RZLT
$421M
$6.05M 4.15%
424,243
– –
CTIC
10
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5.79M 3.96%
2,314,533
-200,114
-8% -$480K
ADXN
11
Addex Therapeutics
ADXN
$7.52M
$2.54M 1.74%
13,297
– –
LUXA
12
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
$1.98M 1.36%
200,000
– –
AAC.U
13
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$1.4M 0.96%
139,680
-2,320
-2% -$23.3K
ISEE
14
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.28M 0.88%
203,414
+56,048
+38% +$362K
EIGR
15
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.18M 0.81%
4,621
+1,485
+47% +$371K
GOOG icon
16
Alphabet (Google) Class C
GOOG
$4.32T
$933K 0.64%
7,440
+3,160
+74% +$377K
INTU icon
17
Intuit
INTU
$80.6B
$924K 0.63%
1,885
+805
+75% +$349K
META icon
18
Meta Platforms (Facebook)
META
$1.69T
$892K 0.61%
2,566
+1,091
+74% +$350K
PYPL icon
19
PayPal
PYPL
$50B
$892K 0.61%
3,060
+1,303
+74% +$344K
CVNA icon
20
Carvana
CVNA
$50.6B
$872K 0.6%
14,440
+6,140
+74% +$334K
CDLX icon
21
Cardlytics
CDLX
$24M
$864K 0.59%
681
+302
+80% +$341K
MCO icon
22
Moody's
MCO
$90.7B
$863K 0.59%
2,382
+1,020
+75% +$339K
SPGI icon
23
S&P Global
SPGI
$135B
$851K 0.58%
2,073
+884
+74% +$340K
MSFT icon
24
Microsoft
MSFT
$2.98T
$829K 0.57%
3,059
+1,308
+75% +$332K
V icon
25
Visa
V
$694B
$822K 0.56%
3,516
+1,498
+74% +$342K
1
2 3

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q2 2021 Portfolio in Review

As of Q2 2021, Caxton Corporation held 70 positions worth $146M, down 5.2% from $154M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Caxton Corporation deployed $7.94M of net new capital in Q2 2021, opening 1 new position and adding to 28 existing holdings. Its largest new stake was Elevation Oncology: 39,586 shares worth $537K.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 81% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Cazoo Group Ltd, an estimated $579K trimmed.

  • Caxton Corporation's largest Q2 2021 buy was Elevation Oncology: 39,586 shares worth $537K.
  • Caxton Corporation added most to Cardiff Oncology in Q2 2021, an estimated $1.94M increase.
  • Caxton Corporation's biggest Q2 2021 reduction was Cazoo Group Ltd, cutting an estimated $579K.
  • Caxton Corporation fully exited Enjoy Technology, Inc. Common Stock in Q2 2021, selling an estimated $1.04M.
  • Caxton Corporation's ten largest holdings make up 78% of its $146M portfolio in Q2 2021.
  • Caxton Corporation opened 1 new position and closed 7 in Q2 2021.
  • Caxton Corporation's portfolio value fell 5.2% quarter-over-quarter to $146M.

Based on Caxton Corporation's 13F filing for Q2 2021, filed 16 Aug 2021.